Journal Article

A simple approach for assessing equilibrated Kt/<i>V</i><sub>β2-M</sub> on a routine basis

Francesco G. Casino, Luciano A. Pedrini, Antonio Santoro, Salvatore Mandolfo, Salvatore David, Vincenzo De Cristofaro, Ugo Teatini, Carlo Lomonte and Teodoro Lopez

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 25, issue 9, pages 3038-3044
Published in print September 2010 | ISSN: 0931-0509
Published online March 2010 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/gfq173
A simple approach for assessing equilibrated Kt/Vβ2-M on a routine basis

Show Summary Details

Preview

Background. Large observational studies have shown a reduction in morbidity and mortality in patients on high-flux haemodialysis (HD) or convective techniques, compared with low-flux HD. An index to evaluate treatment efficiency in middle molecule (MM) removal would be recommended. Since beta-2-microglobulin (β2-M) is a recognized MM marker, we evaluated an easy approach for Kt/Vβ2-M assessment on a routine basis, avoiding other complex methods.

Methods. An equation that estimates single-pool (sp) Kt/Vβ2-M was derived from Leypoldt's formula, which calculates β2-M dialyser clearance (Kβ2-M) from the post/pre-dialysis β2-M concentration (Ct/C0) ratio and the weight loss/end-dialysis weight (ΔW/W) ratio. Our equation, spKt/Vβ2-M = 6.12 ΔW/W [1 − ln(Ct/C0)/ln(1 + 6.12 ΔW/W)], was derived by assuming urea distribution volume (Vu) as 49% of W and β2-M volume (Vβ2-M) as Vu/3, in agreement with the average patient values in the HEMO Study. The spKt/Vβ2-M values calculated with our equation (F) in 129 patients on 407 sessions of different high-flux treatments were compared with those calculated with the method applied in the HEMO Study (HM). Equilibrated β2-M concentration (Ceq) of the same sessions was also estimated with the equation for Ceq by Tattersall, and equilibrated Kt/V (eKt/Vβ2-M) was calculated by introducing Tattersall's equation into our simplified spKt/Vβ2-M formula.

Results. Mean results of our spKt/Vβ2-M equation (F) were very close to those of the HM method (1.48 ± 0.38 vs 1.47 ± 0.37). The difference was less than ±0.1 in 95% of cases. A mean end-session β2-M rebound of 44 ± 14% was predicted, which caused a mean reduction in actual Kt/Vβ2-M of ~27% (eKt/Vβ2-M = 1.08 ± 0.26).

Conclusions. The method proposed to estimate spKt/Vβ2-M and eKt/Vβ2-M could become a simple tool to monitor the efficiency of high-flux HD and convective techniques and to evaluate the adequacy of treatments in terms of MM removal. Moreover, it might help to better understand the effects of different dialysis schedules. Validation on a larger dialysis population is required.

Keywords: beta-2-microglobulin; EKR; haemodiafiltration; haemofiltration; high-flux haemodialysis

Journal Article.  4425 words.  Illustrated.

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.